Abstract:Poly(ADP-ribosyl)ation is an immediate cellular response to DNA damage generated either exogenously or endogenously. This post-translational modification is catalyzed by poly(ADP-ribose) polymerase (PARP, PARP-1, EC 2.4.2.30). It is proposed that this protein plays a multifunctional role in many cellular processes, including DNA repair, recombination, cell proliferation and death, as well as genomic stability. Chemical inhibitors of the enzyme, dominant negative or null mutations of PARP-1 cause a high degree of genomic instability in cells. Inhibition of PARP activity by chemical inhibitors renders mice or rats susceptible to carcinogenic agents in various tumor models, indicating a role for PARP-1 in suppressing tumorigenesis. Despite the above observations, PARP-1 knockout mice are generally not prone to the development of tumors. An enhanced tumor development was observed, however, when the PARP-1 null mutation was introduced into severely compromised immune-deficient mice (a mutation in DNA-dependent protein kinase) or mice lacking other DNA repair or chromosomal guardian molecules, such as p53 or Ku80. These studies indicate that PARP-1 functions as a cofactor to suppress tumorigenesis via its role in stabilization of the genome, and/or by interacting with other DNA strand break-sensing molecules. Studies using PARP-1 mutants and chemical inhibitors have started to shed light on the role of this protein and of the specific protein post-translational modification in the control of genomic stability and hence its involvement in cancer.

[Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1]

Human PARP1 Substrates and Regulators of Its Catalytic Activity: an Updated Overview.

HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage

HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation

HPF1 remodels PARP1 active site for ADP-ribosylation of histones on serine

HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones

PARPing for Balance in the Homeostasis of Poly(adp-Ribosyl)ation.

PARP1: Liaison of Chromatin Remodeling and Transcription

The Enigmatic Function of PARP1: from PARylation Activity to PAR Readers

The expanding universe of PARP1-mediated molecular and therapeutic mechanisms

The multifaceted roles of PARP1 in DNA repair and chromatin remodelling

Beyond PARP1: The Potential of Other Members of the Poly (ADP-Ribose) Polymerase Family in DNA Repair and Cancer Therapeutics

Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases

Poly‐ADP‐ribosylation dynamics, signaling, and analysis

The dynamics and Regulation of PARP1 and PARP2 in response to DNA damage and during replication

PARP1: Structural insights and pharmacological targets for inhibition

Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis

Kinetics of Poly(adp-Ribosyl)ation, but Not PARP1 Itself, Determines the Cell Fate in Response to DNA Damage in Vitro and in Vivo.

Physiological Functions of Poly(adp-Ribose)polymerase and Potential Clinical Applications of Its Inhibitors

The FHA and BRCT Domains Recognize ADP-ribosylation During DNA Damage Response.

Functions of Poly(adp-Ribose) Polymerase (PARP) in DNA Repair, Genomic Integrity and Cell Death